Publisher
Springer Science and Business Media LLC
Subject
Hematology,General Medicine
Reference77 articles.
1. Appelbaum FR, Gundacker H, Head DR et al (2006) Age and acute myeloid leukemia. Blood. 107(9):3481–3485
2. Kantarjian H, O’brien S, Cortes J et al (2006) Results of intensive chemotherapy in 998 patients age 65 years or older with acute myeloid leukemia or high-risk myelodysplastic syndrome: predictive prognostic models for outcome. Cancer. 106(5):1090–1098
3. Leith CP, Kopecky KJ, Chen IM et al (1999) Frequency and clinical significance of the expression of the multidrug resistance proteins MDR1/P-glycoprotein, MRP1, and LRP in acute myeloid leukemia. a SouthwestOncology Group study. Blood. 94:1086–1099
4. Burnett A, Wetzler M, Lowenberg B (2011) Therapeutic advances in acute myeloid leukemia. J Clin Oncol 29:487–494
5. Fröhling S, Schlenk RF, Kayser S et al (2006) German-Austrian AML Study Group. Cytogenetics and age are major determinants of outcome in intensively treated acute myeloid leukemia patients older than 60 years: results from AMLSG trial AML HD98-B. Blood. 108(10):3280–3288
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献